An Update on Fetal Alcohol Syndrome-Pathogenesis, Risks, and Treatment

Alcohol is a well‐established teratogen that can cause variable physical and behavioral effects on the fetus. The most severe condition in this spectrum of diseases is known as fetal alcohol syndrome (FAS). The differences in maternal and fetal enzymes, in terms of abundance and efficiency, in addit...

Full description

Saved in:
Bibliographic Details
Published in:Alcoholism, clinical and experimental research clinical and experimental research, 2016-08, Vol.40 (8), p.1594-1602
Main Authors: Gupta, Keshav K., Gupta, Vinay K., Shirasaka, Tomohiro
Format: Article
Language:English
Subjects:
Alcohol
Alcohol Drinking - adverse effects
Alcohol Drinking - metabolism
Animals
Cell adhesion & migration
Ethanol - administration & dosage
Ethanol - metabolism
Ethanol - toxicity
Female
Fetal Alcohol Spectrum Disorders - etiology
Fetal Alcohol Spectrum Disorders - metabolism
Fetal Alcohol Spectrum Disorders - therapy
Fetal Alcohol Syndrome
Fetuses
Humans
Maternal-Fetal Exchange - drug effects
Maternal-Fetal Exchange - physiology
Pathogenesis
Pregnancy
Prenatal Treatment
Quality of Life
Risk Factors
Teratogenicity
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Alcohol is a well‐established teratogen that can cause variable physical and behavioral effects on the fetus. The most severe condition in this spectrum of diseases is known as fetal alcohol syndrome (FAS). The differences in maternal and fetal enzymes, in terms of abundance and efficiency, in addition to reduced elimination, allow for alcohol to have a prolonged effect on the fetus. This can act as a teratogen through numerous methods including reactive oxygen species (generated as by products of CYP2E1), decreased endogenous antioxidant levels, mitochondrial damage, lipid peroxidation, disrupted neuronal cell–cell adhesion, placental vasoconstriction, and inhibition of cofactors required for fetal growth and development. More recently, alcohol has also been shown to have epigenetic effects. Increased fetal exposure to alcohol and sustained alcohol intake during any trimester of pregnancy is associated with an increased risk of FAS. Other risk factors include genetic influences, maternal characteristics, for example, lower socioeconomic statuses and smoking, and paternal chronic alcohol use. The treatment options for FAS have recently started to be explored although none are currently approved clinically. These include prenatal antioxidant administration food supplements, folic acid, choline, neuroactive peptides, and neurotrophic growth factors. Tackling the wider impacts of FAS, such as comorbidities, and the family system have been shown to improve the quality of life of FAS patients. This review aimed to focus on the pathogenesis, especially mechanisms of alcohol teratogenicity, and risks of developing FAS. Recent developments in potential management strategies, including prenatal interventions, are discussed. This article is an update on fetal alcohol syndrome (FAS), its pathogenesis, potential treatments, and preventative measures. Risk factors for the development of FAS and alcohol's mechanisms as a teratogen are also discussed. With FAS being the most extreme type of fetal alcohol spectrum disorder, knowledge of this condition can help to tackle alcohol consumption during pregnancy. We invite the readership to gain a detailed yet simple understanding of this broad and complex topic.
ISSN:0145-6008
1530-0277
DOI:10.1111/acer.13135